Literature DB >> 27236641

Effect of diclofenac on SLC16A3/MCT4 by the Caco-2 cell line.

Shotaro Sasaki1, Yuya Futagi1, Masaya Ideno1, Masaki Kobayashi1, Katsuya Narumi1, Ayako Furugen1, Ken Iseki2.   

Abstract

In the present study, we demonstrated that monocarboxylate transporter 4 (MCT4) is functionally expressed in Caco-2 cells. We studied the effects of 4 nonsteroidal anti-inflammatory drugs on the uptake of l-lactate as a good substrate of MCT4 by the cells. The monocarboxylate drugs inhibited the uptake of l-lactate into the cells. Diclofenac, as a member of the aryl-acetic acid group of nonsteroidal anti-inflammatory drugs, was the most potent inhibitor, with an inhibition constant of 20 μM. In the next study, we determined the type of inhibition for diclofenac. An l-lactate carrier is non-competitively inhibitable by the drug. We also demonstrated, in Xenopus oocyte expression system, potential of diclofenac for MCT4 inhibitor. The present results could provide a useful tool to discover MCT4-specific inhibitors.
Copyright © 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diclofenac; Lactic acid; Membrane; Oocyte; Transporter

Mesh:

Substances:

Year:  2016        PMID: 27236641     DOI: 10.1016/j.dmpk.2016.03.004

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  12 in total

1.  Homology modeling and site-directed mutagenesis identify amino acid residues underlying the substrate selection mechanism of human monocarboxylate transporters 1 (hMCT1) and 4 (hMCT4).

Authors:  Yuya Futagi; Masaki Kobayashi; Katsuya Narumi; Ayako Furugen; Ken Iseki
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

2.  Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.

Authors:  Yasna Contreras-Baeza; Pamela Y Sandoval; Romina Alarcón; Alex Galaz; Francisca Cortés-Molina; Karin Alegría; Felipe Baeza-Lehnert; Robinson Arce-Molina; Anita Guequén; Carlos A Flores; Alejandro San Martín; L Felipe Barros
Journal:  J Biol Chem       Date:  2019-11-12       Impact factor: 5.157

Review 3.  Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment.

Authors:  Kathrin Renner; Katrin Singer; Gudrun E Koehl; Edward K Geissler; Katrin Peter; Peter J Siska; Marina Kreutz
Journal:  Front Immunol       Date:  2017-03-08       Impact factor: 7.561

4.  Evaluation of Monocarboxylate Transporter 4 in Inflammatory Bowel Disease and Its Potential Use as a Diagnostic Marker.

Authors:  Liying He; Hongli Wang; Yuhua Zhang; Lanlan Geng; Min Yang; Zhaohui Xu; Kejian Zou; Wanfu Xu; Sitang Gong
Journal:  Dis Markers       Date:  2018-05-08       Impact factor: 3.434

5.  Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.

Authors:  Don Benjamin; Dimitri Robay; Sravanth K Hindupur; Jens Pohlmann; Marco Colombi; Mahmoud Y El-Shemerly; Sauveur-Michel Maira; Christoph Moroni; Heidi A Lane; Michael N Hall
Journal:  Cell Rep       Date:  2018-12-11       Impact factor: 9.423

6.  Matrix Stiffness Modulates Metabolic Interaction between Human Stromal and Breast Cancer Cells to Stimulate Epithelial Motility.

Authors:  Iván Ponce; Nelson Garrido; Nicolás Tobar; Francisco Melo; Patricio C Smith; Jorge Martínez
Journal:  Metabolites       Date:  2021-07-01

7.  Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells.

Authors:  Kathrin Renner; Anton Seilbeck; Nathalie Kauer; Ines Ugele; Peter J Siska; Christina Brummer; Christina Bruss; Sonja-Maria Decking; Matthias Fante; Astrid Schmidt; Kathrin Hammon; Katrin Singer; Sebastian Klobuch; Simone Thomas; Eva Gottfried; Katrin Peter; Marina Kreutz
Journal:  Front Pharmacol       Date:  2018-11-02       Impact factor: 5.810

8.  Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma.

Authors:  Valeria Gerthofer; Marina Kreutz; Kathrin Renner; Birgit Jachnik; Katja Dettmer; Peter Oefner; Markus J Riemenschneider; Martin Proescholdt; Arabel Vollmann-Zwerenz; Peter Hau; Corinna Seliger
Journal:  Int J Mol Sci       Date:  2018-08-31       Impact factor: 5.923

Review 9.  Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities.

Authors:  René G Feichtinger; Roland Lang
Journal:  J Oncol       Date:  2019-11-03       Impact factor: 4.375

Review 10.  Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer.

Authors:  Maritza P Garrido; Allison N Fredes; Lorena Lobos-González; Manuel Valenzuela-Valderrama; Daniela B Vera; Carmen Romero
Journal:  Biomedicines       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.